Therapies for Treating COVID-19

Therapies for Treating COVID-19 | Munson HealthcareMunson Healthcare currently offers two therapies for patients with mild or moderate COVID-19 symptoms that may help patients recover quicker and avoid hospitalization. With our region’s steady COVID-19 positivity rate, these programs are continuously receiving a significant number of patient and provider referrals.

Ask-A-Nurse   Learn More

For Referring and  Treating Providers

Paxlovid Therapy for Treating COVID-19

What is Paxlovid Therapy?

Paxlovid is a first line therapy medicine used to treat mild-to-moderate COVID-19. Paxlovid can be used in adults and children who meet the following criteria:

  • Are 12 years of age and older
  • Weigh at least 88 pounds
  • Have a positive test for the COVID-19 virus
  • And, are at high risk for progression to severe COVID-19

When started within 5 days of symptom onset, Paxlovid keeps the virus that causes COVID-19 from reproducing, preventing symptoms from progressing. It reduces the risk of hospitalization and death for patients at high risk of disease progression.

To learn more about Paxlovid, visit the MDHHS Paxlovid Information for the Public webpage.

How to Qualify for Paxlovid Therapy

The FDA has authorized the emergency use of Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and children who meet the above criteria.

A healthcare provider will determine if you are a candidate for Paxlovid, which requires a prescription. To further discuss treatment for COVID-19, connect with your primary care provider, or consider Munson Healthcare’s Virtual Urgent Care service.

To determine if Paxlovid is right for you, discuss with your medical provider:

  • Any known allergies
  • Diagnosis of liver or kidney disease
  • If you are pregnant, plan to become pregnant or are breastfeeding a child
  • Have any serious illnesses
  • Any/all current medications and supplements you take
Will Insurance Cover Paxlovid Therapy?

Currently, Paxlovid is provided by the federal government at no charge. Some dispensing pharmacies may bill insurance providers for the cost of dispensing the medication. Patients should not experience out-of-pocket costs.

Contact your primary care provider, or consider the Munson Healthcare Virtual Urgent Care to discuss treatment for COVID-19 with a healthcare provider.


Monoclonal Antibody Therapy

What is Monoclonal Antibody Therapy?

Monoclonal antibodies are lab-produced molecules that can mimic the immune system’s ability to fight viruses and other harmful pathogens. The FDA has authorized the emergency use of monoclonal antibodies for the treatment of COVID-19 under an Emergency Use Authorization (EUA). This infusion therapy targets different parts of the COVID-19 virus and prevents it from bonding with cells in the body.

How to Qualify for Monoclonal Antibody Therapy

Patients must be age 12 or older, weigh at least 88 pounds, have a documented positive COVID-19 test and at least one qualifying health condition to be eligible. Therapy must be administered within 7 days of the onset of symptoms. Please call your primary care provider or Munson Healthcare Ask-a-Nurse at 231-935-0951 to discuss treatment options.

Where to Receive Monoclonal Antibody Therapy

Munson Healthcare patients will be contacted for scheduling monoclonal antibody therapy when all of their required provider or self-referral  information is received and there is an appointment available within ten days of symptom onset.

Additional Monoclonal Antibody Therapy Referral Number:

Does Insurance Cover Monoclonal Antibody Therapy?

Monoclonal antibody therapy is covered by most health insurance policies. Please check with your individual plan to understand how this treatment will be billed. If you don’t have health insurance, please call Munson Healthcare Ask-a-Nurse at 231-935-0951. Funds can be made available to cover the cost of your treatment.